Explore why generic specialty drugs still require specialty pharmacy distribution. Learn about biosimilars, provider roles, and how to navigate complex dispensing workflows in 2026.
read more
Learn the difference between biosimilars and authorized generics, how interchangeable biologics work, and why these alternatives are key to lowering drug costs.
read more
Generic drugs are evolving from low-cost copies to high-stakes biotech products. Discover how biosimilars, supply chain shifts, and emerging markets will reshape global healthcare access by 2030.
read more